The University of Kansas Cancer Center, Investigational Drug Services — Westwood, Kansas

The University of Kansas Cancer Center, Investigational Drug Services is a clinical research site located in Westwood, Kansas, United States 66205.

Crixeo Clinical Trials Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Cancer Center, Investigational Drug Services has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, BRAF V600E-mutant Metastatic Colorectal Cancer, Melanoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Westwood

Browse all research sites in Kansas · View every site in Westwood

• University of Kansas Cancer Center - Richard and Annette Bloch Cancer Care Pavilion
• Kansas City VA Medical Center
• University of Kansas Medical Center
• (185) The University of Kansas Cancer Center
• University of Kansas Medical Center Breast Cancer Prevention Center
• University of Kansas; Medical Center & Medical pavilion
• The University of Kansas Cancer Center and Medical Pavillion
• University of Kansas Hospital Authority
• The University of Kansas Cancer Center and Medical Pavilion
• University of Kansas Cancer Center - The Richard and Annette Bloch Cancer Care Pavilion,2330 Shawnee Mission Parkway
• University Of Kansas Cancer Center And Medical Pavillion
• The University of Kansas Cancer Center-Westwood

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Cancer Center, Investigational Drug Services?

The University of Kansas Cancer Center, Investigational Drug Services has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Cancer Center, Investigational Drug Services conducted?

The University of Kansas Cancer Center, Investigational Drug Services has 5 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, BRAF V600E-mutant Metastatic Colorectal Cancer, Melanoma.

Is The University of Kansas Cancer Center, Investigational Drug Services accredited by Crixeo Clinical Trials?

The University of Kansas Cancer Center, Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of Kansas Cancer Center, Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.